Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study Evaluating the Safety and Efficacy of Roflumilast in Type 2 Diabetic Patients With Diabetic Neuropathy

NCT05369793 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT05369793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05369793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study Evaluating the Safety and Efficacy of Roflumilast in Type 2 Diabetic Patients With Diabetic Neuropathy
Lead sponsor
Tanta University
Phase
Phase 3
Overall status
Completed
Start date
August 1, 2022
Completion date
October 10, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic neuropathies, type 2 diabetes (adult onset)